Latest Stock Market News

Spot gold was up 0.2% at $1,819.71 per ounce, as of 0046 GMT. Earlier in the session, bullion hit a peak since Aug. 4 at $1,820.50.

Traders taking bets on futures and options (F&O) markets will have to shell out higher margin money making these trades more expensive. Essentially, they are required to cough up 100 per cent of margin upfront under the new peak margin norms.

Brent crude was up by 84 cents or 1.2% at $73.54 a barrel by 0001 GMT, after gaining more than 11% last week in anticipation of disruptions to oil production. US oil gained 53 cents or 0.8% at $69.27 a barrel, having jumped a little over 10% over last week.

The survey also said about 46 per cent of the 117 CEOs, who participated in the survey, expected more than 10 per cent revenue growth of their respective company in the first half of the current fiscal as compared to the first half of pre-pandemic year 2019-20.

Around $200-250 million have been raised by such companies from investors since January, data compiled by ET shows.

Projects on India’s western coast, including these two 4,000 MW plants run by Tata Power and Adani Power, use imported coal, but are not operating now in the absence of compensation for high fuel cost, the official said.

While Cloudnine may be raising Rs 2,500-3,500 crore, Medanta is looking to mop up about Rs 2,000 crore and the Park Group of Hospitals is targeting around Rs 800 crore, they said. They IPOs will include newly issued shares as well as sale of stake by some existing investors.

As per the report by the USFDA, Zydus Pharmaceuticals (USA) Inc, is recalling 2,880 bottles of Carvedilol tablets, USP 25 mg in the US due to, "presence of foreign tablets/ capsules; report of two Paroxetine tablets were found in the bottle."

Read more on what to bet on for taking cover from Fed’s tapering, the sectoral winners going ahead, key metrics’ warning for the smallcap space and much more in this week’s edition of ‘Long & Short of Markets’.

The market is getting increasingly stock-specific in nature. We recommend continuing to adopt a highly selective approach while approaching the markets. Select banks and pharma stocks are expected to show improved relative performance and some select mid-caps can do good as well. However, the market is unlikely to see any sector-specific dominant participant.